$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Introduction to the indications and treatment scope of Erdafitinib/Bocco
2026-02-01 22:25:32
Check Details
Correct usage, dosage and medication recommendations of Dacomitinib/Dozerun
2026-02-01 22:25:32
Check Details
Has brigatinib/brigatinib been reimbursed by medical insurance?
2026-02-01 22:25:32
Check Details
Correct usage and dosage of entrectinib/Luo Shengquan
2026-02-01 22:25:32
Check Details
How to prevent the side effects and harms of Sorafenib/Nexavar
2026-02-01 22:25:32
Check Details
Will the side effects of Pemetinib/Dabotan persist?
2026-02-01 22:25:32
Check Details
Where to buy Erdafitinib more formally
2026-02-01 22:25:32
Check Details
Are Dacomitinib/Dacomitinib and Dozerun the same drug?
2026-02-01 22:25:32
Check Details
Brigatinib/Brigatinib (Embry) treatment effects and patient feedback
2026-02-01 22:25:32
Check Details
What is the brand name of Entrectinib?
2026-02-01 22:25:32
Check Details
What type of drug does Guanfacine belong to?
2026-02-01 22:25:32
Check Details
What is the difference between Acotiamide and Mosapride
2026-02-01 22:25:32
Check Details
1
2
...
2007
2008
2009
2010
2011
2012
2013
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
2
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
3
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
4
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
5
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
6
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
7
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
8
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
9
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
10
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
11
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
12
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials